Therefore, we observed the effect of LXJDF on the IMQ-induced ApoE−/− mice model to study the intervention of LXJDF on psoriasis and dyslipidemia comorbidity via regulating the PI3K/Akt/mTOR pathway. The gene discussed is AKT1; the disease is metabolic syndrome.